Cormedix Inc.
Pharmaceutical ManufacturingView the employees at
Cormedix Inc.-
Beatriz Dunning Executive Director of Clinical Affairs at CORMEDIX INC.
-
Myrtle Beach, South Carolina, United States
-
Rising Star
Hunter Kane (Snyder) Senior Manager, Brand Media and Communications-
Greater Boston
-
Rising Star
Liz Hurlburt Executive Vice President, Head of Clinical and Medical Affairs at CorMedix-
Simsbury, Connecticut, United States
-
Top 5%
Peter Sullivan PharmD, BCOP, ACE Executive Director, Strategic Partnerships at CorMedix Inc. (NASDAQ: CRMD)-
Rising Star
Overview
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. For more information, visit: www.cormedix.com.
-